Ticlopidine-induced severe agranulocytosis after the placement of coronary artery stent: A case report

Angiology

Volumn 51, Issue 7, 2000, Pages 591-593

  Sari, Ramazan ^a   Sevinc, Alper ^a   Buyukberber, Suleyman ^a  

^a INONU UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFTAZIDIME; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TICLOPIDINE;

ADULT; AGRANULOCYTOSIS; ARTICLE; BLOOD CELL COUNT; CASE REPORT; CORONARY STENT; FEBRILE NEUTROPENIA; FEMALE; HUMAN;

EID: 0033941163     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331970005100707     Document Type: Article

References (20)

1. Young NS: Agranulocytosis. JAMA 271:935-938, 1994.
2. Keeling RP: Non-neoplastic disorders of granulocytes and monocytes. In: Fundamentals of Clinical Hematology, ed. 5, ed. by Thorup OA. Philadelphia: WB Saunders, 1987, pp 424-459.
3. Hass WK, Easton JD, Adams HP, et al: A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high risk patients. N Engl J Med 321:501-507, 1989.
4. Schoming A, Neumann FJ, Kastrati A, et al: A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary artery stents. N Engl J Med 334:1084-1089, 1996.
5. Lesesve JF, Callat MP, Lenormand B, et al: Hematological toxicity of ticlopidine. Am J Hematol 47:149-150, 1994.
6. Gardner FH: Ticlopidine induced neutropenia: Recognition and management. Intern Med 12:35-41, 1991.
7. Marinella MA: Reversible hyperkalemia associated with trimethoprim-sulfametnoxazole. Am J Med Sci 310:115-117, 1995.
8. Marquez JA, Pardo C, Amutio E, et al: Drug-induced agranulocytosis: Clinical study of 19 cases. Sangre 43:436-438, 1998.
9. Garnier G, Taillan B, Pesce A, et al: Ticlopidine and severe aplastic anemia. Br J Haematol 81:459-460, 1992.
10. Guerciolini R, Giordano G, Aversa F, et al: Anaemia and agranulocytosis associated with ticlopidine therapy. Acta Haematol 73:232-234, 1985.
11. Bedani PL, Fiocchi O, Scapoli PL, et al: Leukopenia due to ticlopidine in a patient with chronic renal failure. Haematologica 69:641-642, 1984.
12. Mataix R, Ojeda E, Perez MDC, et al: Ticlopidine and severe aplastic anemia. Br J Haematol 80:125-126, 1992.
13. Troussard X, Mayo P, Mosquet B, et al: Ticlopidine and severe aplastic anemia. Br J Haematol 82:779-780, 1992.
14. Khelif A, Assouline D, Ffrench M, et al: Ticlopidine and severe aplastic anemia. Br J Haematol 83:678-679, 1993.
15. Haushofer A, Halbmayer WM, Pracher H: Neutropenia with ticlopidine plus aspirin. Lancet 349:474-475, 1987.
16. Ono K, Kurohara K, Yoshihara M, et al: Agranulocytosis caused by ticlopidine and its mechanism. Am J Hematol 37:239-242, 1991.
17. Quaglino D, Salladini G, Ricciotti M: Possible mechanism of action of ticlopidine on committed granulocyte macrophage precursors. Haematologica 69:257-262, 1984.
18. Martin-Nunez G, Fdez-Soria RR, Sanchez-Gil F, et al: Aplastic anemia and ticlopidine. Br J Haematol 85:633, 1993.
19. Korkmaz ME, Cekin AH: Bone marrow suppression and Klebsiella pneumonia septicemia due to ticlopidine and successful treatment with filgrastim: A case report. Int J Cardiol 66:317-318, 1998.
20. Szto GY, Linnemeier TJ, Ball MW: Fatal neutropenia and thrombocytopenia associated with ticlopidine after stenting. Am J Cardiol 83:138-139, 1999.